Intensifying glycaemic control with insulin reduces adiponectin and its HMW isoform moderately in type 2, but not in type 1, diabetes

Diabetes and Metabolism

Volumn 37, Issue 3, 2011, Pages 259-261

  Abi Khalil, C ^a,b,c   Mohammedi, K ^a,b,c   Aubert, R ^b   Travert, F ^a   Hadjadj, S ^b,d   Roussel, R ^a,b,c   Fumeron, F ^b,c   Marre, M ^a,b,c  

^a BICHAT HOSPITAL   (France)

^b INSERM   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d POITIERS UNIVERSITY HOSPITAL   (France)

Author keywords

Adiponectin; Glycaemic control; Type 1 diabetes mellitus; Type 2 diabetes mellitus

Indexed keywords

ADIPONECTIN; ANTIHYPERTENSIVE AGENT; HEMOGLOBIN A1C; INSULIN;

ADULT; ARTICLE; DRUG MECHANISM; FEMALE; GLYCEMIC CONTROL; HOSPITALIZATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MOLECULAR WEIGHT; NON INSULIN DEPENDENT DIABETES MELLITUS;

ADIPONECTIN; ADULT; AGED; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN; MALE; MIDDLE AGED; PROTEIN ISOFORMS;

EID: 79958865844     PISSN: 12623636     EISSN: 18781780     Source Type: Journal    
DOI: 10.1016/j.diabet.2010.12.001     Document Type: Article

References (13)

1. Hadjadj S., Aubert R., Fumeron F., Pean F., Tichet J., Roussel R., et al. Increased plasma adiponectin concentrations are associated with microangiopathy in type 1 diabetic subjects. Diabetologia 2005, 48:1088-1092.
2. Looker H.C., Krakoff J., Funahashi T., Matsuzawa Y., Tanaka S., Nelson R.G., et al. Adiponectin concentrations are influenced by renal function and diabetes duration in Pima Indians with type 2 diabetes. J Clin Endocrinol Metab 2004, 89:4010-4017.
3. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin dependent diabetes mellitus. N Engl J Med 1993, 329:977-986. Diabetes Control and Complications Trial Research Group.
4. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998, 352(9131):837-853. UK Prospective Diabetes Study (UKPDS) Group.
5. Frystyk J., Tarnow L., Krarup Hansen T., Parving H.H., Flyvbjerg A. Increased serum adiponectin levels in type 1 diabetic patients with microvascular complications. Diabetologia 2005, 48:1911-1918.
6. Stadler M., Storka A., Theuer E.A., Krebs M., Vojtassakova E., Nowotny P., et al. Adipokines in type-1 diabetes after successful pancreas transplantation: Normal visfatin and retinol-binding-protein-4, but increased total adiponectin fasting concentrations. Clin Endocrinol (Oxf) 2010, 72:763-769.
7. Imagawa A., Funahashi T., Nakamura T., Moriwaki M., Tanaka S., Nishizawa H., et al. Elevated serum concentration of adipose-derived factor, adiponectin, in patients with type 1 diabetes. Diabetes Care 2002, 25:1665-1666.
8. Blümer R.M., van der Crabben S.N., Stegenga M.E., Tanck M.W., Ackermans M.T., Endert E., et al. Hyperglycemia prevents the suppressive effect of hyperinsulinemia on plasma adiponectin levels in healthy humans. Am J Physiol Endocrinol Metab 2008, 295:E613-E617.
9. Möhlig M., Wegewitz U., Osterhoff M., Isken F., Ristow M., Pfeiffer A.F., et al. Insulin decreases human adiponectin plasma levels. Horm Metab Res 2002, 34:655-658.
10. Basu R., Pajvani U.B., Rizza R.A., Scherer P.E. Selective downregulation of the high molecular weight form of adiponectin in hyperinsulinemia and in type 2 diabetes: differential regulation from nondiabetic subjects. Diabetes 2007, 56:2174-2177.
11. Fernández-Real J.M., Botas-Cervero P., López-Bermano A., Casamitjana R., Funahashi T., Delgado E., et al. Adiponectin is independently associated with glycosylated haemoglobin. Eur J Endocrinol 2004, 150:201-205.
12. Owecki M., Miczke A., Pupek-Musialik D., Bryll W., Cymerys M., Nikisch E., et al. Serum adiponectin concentrations are not related to glycosylated hemoglobin levels (HbA1c) in obese diabetic and non-diabetic caucasians. Exp Clin Endocrinol Diabetes 2008, 116:173-177.
13. Weyer C., Funahashi T., Tanaka S., Hotta K., Matsuzawa Y., Pratley R.E., et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001, 86:1930-1935.